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Previewsconformation in the active site (Hsiao
et al., 2011). Because only single-
stranded RNA was used for this study
(Romano et al., 2014), it will be interesting
to know if RNase AS can also degrade
double-stranded RNA with 30 overhangs
and whether its activity will be blocked
by double-stranded structures.
In prokaryotes, the poly(A) tail func-
tions in the regulation of RNA stability
andquality control (Mohanty andKushner,
2011). Given that RNase AS and PARN
[a poly(A)-specific 30 exoribonuclease of
the DEDDh subfamily; Wu et al., 2005]
share a similar substrate preference,
and the latter is a key deadenylase in
eukaryotic mRNA turnover, RNase AS
is likely involved in mRNA decay through664 Structure 22, May 6, 2014 ª2014 Elsevieshortening of the 30 adenylate-con-
taining mRNA. However, the transcripts
targeted by RNase AS are not known.
One of the future goals is to identify
the genes responsible for the mycobacte-
rial virulence whose stability is regulated
by RNase AS through deadenylation.
Identification of the physiological sub-
strates of RNase AS and elucidation
of the catalytic mechanism of this impor-
tant RNase would greatly aid the drug
design efforts toward more efficient TB
therapy.REFERENCES
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In this issue of Structure, Tre´saugues and colleagues determined the interaction of membrane-bound
phosphoinositides with three clinically significant human inositol polyphosphate 5-phosphatases (I5Ps). A
comparison to the structures determined with soluble substrates revealed differences in the binding mode
and suggested how the I5Ps and apurinic endonuclease (APE1) activities evolved from the samemetal-bind-
ing active center.A complex family of membrane-bound
inositol-lipid conjugates plays a central
role in cell proliferation, synaptic vesicle
recycling, and actin polymerization.
Control of these pathways depends on a
family of enzymes that control the phos-
phorylation of insoluble phosphoinositi-
des (PtdIns), i.e., glycerolphospholipids
bound to the 1-hydroxyl of myo-inositol.
Specific kinases add phosphate groups
at the 3, 4, and 5 hydroxyls of the inositol
ring, leading to seven different isoforms.
These, in turn, are removed by a family of
phosphatases. In this issue of Structure,
Tre´saugues et al. (2014) show the binding
site for three human phosphatases thatremove the 5-phosphate from PtdIns
with two or three phosphates bound to
PtdIns. Mutations in the similar 5-phopha-
tase active site of these enzymes are
related to Lowes syndrome and Dent dis-
ease (5-phosphatase OCRL), character-
ized by renal failure, as well as defects in
insulin signaling and obesity (5-phopha-
tase SHIP2). They also determined the
structure of INPP5B, whose similarity in
substrate specificity to OCRL suggests
it may have overlapping function. The
details of these new structures could
help in the design of treatments for renal
syndromes. Inhibitors of SHIP2 might
even be novel weight-loss medications,because mice deficient in SHIP2 were
resistant to diet-induced obesity.
These structures are most remarkable
for the details they can shed on how in-
soluble inositides bind, because the only
structure of a 5-phosphatase catalytic
domain previously reported is that of a
complex ofSchizosaccharomyces pombe
synaptojanin (SPsynaptojanin) with a sol-
uble ligand (Tsujishita et al., 2001). They
are also important for the details they pro-
vide on a unifying mechanism for dephos-
phorylation of PtdIns with other types of
phospho-transfer reactions.
The inositol position is different in
the new structures from models of the
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SPsynaptojanin structure as a template.
Although the active site clefts of the three
human enzymes overlay well with that
of SPynaptojanin, the orientation of the
inositol in themembrane-bound substrate
was dramatically different, by a rotation of
about 100 from that seen in the binding of
soluble substrates. The structures estab-
lished two new lipid recognition motifs
within the human enzymes that contribute
to the recognition of the fatty acid part of
the substrate. These membrane binding
regions contain hydrophobic residues in
most members of the 5-phosphatase
family and could therefore be valuable
targets for inhibitor design.
Unfortunately, the study did not reveal
allosteric mechanisms that would corre-
late lipid binding with the catalytic activity
at the P5 position. The inositol ring is not
planar, and addition of phosphates at
different positions alters its 3D pucker.
Therefore, even small changes in its
binding mode can be very important for
designing specific inhibitors. The inter-
actions of the phosphates in the inositol
ring to the enzymes are mainly through
positively charged Lys or Arg residues, a
feature found in other inositol phosphate
complexes. This is consistent with, for
example, the relatively surface exposed
activator site for inositol-6-phosphate
(phytic acid) in the cysteine protease
domains of Vibrio cholera or toxin B of
Clostridium difficile (Pruitt et al., 2009;
Lupardus et al., 2008). There, while each
Pi is bound by several positively charged
side chains, there are no direct contacts
to the ring. This suggests that a flexible
binding site may be necessary to allow
for changes in configuration of the ring
induced by phosphorylation changes.
Tre´saugues et al. (2014) provide
convincing evidence for a similar active
center for the 5-inositol phosphatases
and the apurinic base excision repair
endonucleases that had previously been
predicted by fold recognition methods,
sequence conservation, local structural
similarities (molegos), and mutagenesis
studies (Whisstock et al., 2000; Schein
et al., 2002). The authors compared
the cleft where the scissile 5-P was
observed in the (postcleavage) 5-phos-
phatase structures and the single Mg2+
ion site to structures of the substrate/
metal/enzyme complexes determined for
APE1. The position of conserved resi-dues, including two aspartates, a gluta-
mate, and especially the catalytic Asp/
His pair (D308/H309 in APE1;D523/H524
in OCAL) are essentially superimposable
across the five different proteins: the three
human 5-phosphatases, SPsynaptojanin,
and human APE1.
The conserved geometry suggests
that the phosphatase and nuclease func-
tion of those distantly related enzymes
could arise from an earlier phosphor-
transferase mechanism, perhaps from
small sequence blocks that eventually
became incorporated into larger, more
specific enzymes (Schein et al., 2005;
Mathura et al., 2003).
The question is: which came first, the
phosphatase or the nuclease? A recent
paper from Tainer and colleagues (Tsuta-
kawa et al., 2013) suggests the latter.
They were able to show that the active
site of a repair enzyme with a different
global fold, the bacterial endonuclease
IV DNA (Nfo), was structurally related to
that of APE1. Here, Zn2+ metal ions were
able to assume the role of the conserved
His residues in the I5P/APE1/Synaptoja-
nin family. This example of a convergent
evolution of the catalytic sites of the two
endonucleases and the similarity of the
5-phosphatase and APE1 nuclease func-
tional centers demonstrated in this paper
show the strong structural requirement
for a metal-based dephosphorylation
and could mean that an analogous func-
tional site might have even predated the
enzymatic biological world. These recent
observations on the structural and func-
tional plasticity of catalytic active sites
can fuel further research to explore poten-
tial pathways in the molecular evolution of
functional sites, but they also pose a gen-
eral question: what structural local simi-
larities of functional sites are typically
observed in distantly related enzymes?
The authors postulate a single metal
transition state for the 5-phosphatases,
based on their finding of only one magne-
sium ion in the OCRL active site. The
question of exactly how many metals are
required for cleavage and product release
may seem esoteric, because reactions
are usually run at concentrations that
greatly exceed the molar equivalents of
the enzyme or the substrate. It should
be noted that the position of catalytic
metal ions is difficult to ascertain in the
phosphatases for several reasons. First,
the presumed natural cofactor, Mg2+, isStructure 22, May 6, 2014a small ion that is hard to discriminate
fromwater except in high resolution struc-
tures. Thus, many structures are done
with larger metal ions, such as Mn2+, or,
in the case of APE1, even Yb3+ (a metal
that enhances catalysis) or Pb2+ (which
inhibits it). Second, the phosphate sub-
strates themselves are Mg2+ ion magnets,
meaning that the metal ions may be
chelated by one residue of the protein
(typically an aspartate) with waters or
phosphate groups from the substrate.
Finally, the metal ions may bind to other
places on the protein or substrate, even,
in some cases, stabilizing parts of the
structure.
Previous phosphatase mechanisms
have postulated that two or even three
Mg2+ ions (Li et al., 2010; Gruninger
et al., 2008) are necessary for activity. Tre´-
saugues et al. (2014) point out that the sin-
gle metal they observed is close to, but
not identical to, that found in the single
metal (Yb3+) structure of APE1 (Mol
et al., 2000) and nearly identical to the A
position in the two-metal lead structure.
APE1 is not strictly dependent on metal
ions at all, with limited activity seen even
in the presence of EDTA. We have sug-
gested, based on molecular dynamics
simulations of several different APE1
structures differing in the bound substrate
andmetal ion, that catalysis in APE1 could
be done with one metal, whose pre- and
postcleavage positions are different. The
‘‘moving metal,’’ by accompanying the
rotation of the phosphate during cleav-
age, could aid in rendering the reaction
irreversible and facilitate transfer of the
substrate to the next enzyme in the BER
pathway (Oezguen et al., 2007, 2011;
Schein et al., 2005). Because pre- and
postcleavage positions for the metal
ion may be quite different, details of
the transition state of the I5Ps will thus
depend on analysis of the enzymes bound
to the uncleaved substrate as well as the
products of the reaction.
In summary, thesenewco-crystal struc-
tures of human I5Ps, while confirming
many details of other structures, have re-
vealed some new and possibly controver-
sial details ofmetal-ion-based cleavage of
specific phosphate groups from themem-
brane-bound inositides. Because muta-
tions in the three enzymes are directly
linked to a variety of medical symptoms,
these structures can have an important
impact on the development of new drugs.ª2014 Elsevier Ltd All rights reserved 665
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In this issue of Structure, Marcoux and colleagues use gas-phase collisional cross section (CCS) measured
by ion-mobility mass spectrometry to analyze the CCS of oligomeric states of E. coli outer membrane OmpA.
CCS of the dimer supports a model of paired periplasmic C-terminal domains projecting away from the
transmembrane porins.The development of ion mobility mass
spectrometry (IMS) has enabled the mea-
surement of gas-phase collisional cross
section (CCS) (Bohrer et al., 2008;
Uetrecht et al., 2010). In this case, during
their flight through the mass spectrom-
eter, ions cross a specialized cell of
inert drift gas under the influence of
an electric field such that their shapes
modulate their velocity, achieving a sepa-
ration similar to the one obtained during
electrophoresis. Exit of ions from the
ion mobility cell is monitored by fast m/z
measurement, allowing calibration with
molecules of known shape/CCS and
mass. IMS can thus be used to see if
gas-phase structures are in agreement
with the equivalent aqueous or crystalline
species.
A major application for IMS is emerging
in the study of native protein complexes
largely because of the ability to measure
CCS accurately, alongside mass, on
time-of-flight instruments with extended
m/z capabilities. The extra dimension of
separation achieved with an ion-mobilityseparation prior to MS yields significant
benefits in the simplification of spectra
that might otherwise be uninterpretable.
Importantly, complexes have been ob-
served collapsing to states with smaller
CCS or extending to states with larger
CCS while maintaining their native oligo-
meric status (Ruotolo et al., 2005). Robin-
son’s group pioneered the electrospray-
ionization MS of native complexes and
were the first to apply this technique to
integral membrane proteins a decade
ago when they demonstrated that deter-
gent molecules retained after spraying
micellar solutions of EmrE could be
removed by gas-phase dissociation, with
the dimeric protein retaining a bound
cofactor through to the mass analyzer
(Ilag et al., 2004). Considerable progress
toward understanding native MS of mem-
brane protein complexes has been made
in the subsequent 10 years (Whitelegge,
2013; Laganowsky et al., 2013), and it is
now possible tomake confident measure-
ments of membrane protein CCS for com-
parison with structural models.The porin OmpA is the most abundant
Escherichia coli outer membrane pro-
tein, but its functional significance is
controversial because it is difficult to
reconcile observed conductance mea-
surements with an eight-stranded b-bar-
rel formed by the N-terminal porin
domain alone. Recently, in vivo cross-
linking of E. coli cells with a specialized
tri-functional reagent provided sound ev-
idence for the presence of OmpA dimers
in the outer membrane (Zheng et al.,
2011). The distance constraints intro-
duced by the reagent and the identity
of the crosslinking sites localize the re-
gion responsible for dimerization to the
‘‘disordered’’ C-terminal domain. This
crosslinking information provided the
opportunity to model various potential
dimer structures, and, more recently,
to test these models via calculation of
their respective CCSs for comparison
to IMS measurements.
In this issue of Structure, Marcoux
et al. (2014) found that native IMS of
OmpA preparations revealed a mixture
